Marlborough Life Science Co’s in the News

Groundbreaking embryonic stem cell study gets green light in Europe

August 23, 2011 – Vention Medical, which has operations in Marlborough under the name TDC Medical MA, has purchased an Irish catheter company. Vention Medical is a medical device company specializing in medical balloons, shrink tubing and catheter assembly. It has locations in New Hampshire, Connecticut, New Jersey, Puerto Rico, California and Colorado in addition to the Marlborough facility…read more

————————————————————————————————-

Marlborough’s IQuum gets FDA approval

August 23, 2011 – Marlborough testing company IQuum has received regulatory approval to market its flu testing device in the United States. The company’s Liat Influenza Assay and Liat Analyzer allows doctors and health care staff to test and detect the flu in as little as 20 minutes, according to IQuum…read more

————————————————————————————————-

CardioFocus light-driven endoscopic ablation isolates pulmonary veins for AF treatment

July 22,  2011 – A recent study suggests that the HeartLight endoscopic ablation system from CardioFocus (Marlborough, MA) for transcatheter treatment of atrial fibrillation (AF) enables a pulmonary vein (PV) acute isolation rate of nearly 99%, with approximately 86% of PVs remaining persistently isolated after three months. Additional research also suggests that 65% of patients achieve durable freedom from AF after one procedure…read more

————————————————————————————————

ACT Signs License Agreement with South Korean Company

July 25, 2011 – Advanced Cell Technology Inc. of Marlborough has reached an agreement with South Korean biotechnology company CHA Bio & Diostech Co. Ltd. to deepen their collaboration in an existing joint venture…read more

————————————————————————————————-

Skyscape’s CardioSource App Experiences Record Number of Downloads

July 12, 2011 – Skyscape, Inc., a subsidiary of Physicians Interactive Holdings and leading provider of mobile apps trusted by more than one million healthcare professionals, recently partnered with the American College of Cardiology (ACC) to develop the CardioSource Mobile App. Since its April 2 launch, CardioSource has been downloaded more than 14,000 times by healthcare professionals looking to make smarter decisions in real-time by accessing the most current content and studies in the field of cardiology…read more

————————————————————————————————-

Xcellerex Introduces 10 Liter XDR‐10 Single‐use Bioreactor

July 1, 2011 – Xcellerex, Inc. announced that it has introduced the XDR10, a new 10 liter version of its industry leading XDR line of single use bioreactors. The XDR10 joins an existing lineup that includes units with nominal working volumes of 50, 200, 500, 1,000 and 2,000 liters…read more

————————————————————————————————-

New Qteros Patents

June 27, 2011 – Qteros, the Marlborough company working on microbe-based ethanol production, has received new patent protection for its technology. Qteros, and its academic partner, the University of Massachusetts Amherst, received a patent from the U.S. Patent and Trademark Office covering the development of genomes and use of gene combinations in microorganisms to enhance ethanol production…read more 

————————————————————————————————-

ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells

June 16, 2011 – Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patients were enrolled at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA)…read more

————————————————————————————————-

Spectra Analysis Launches $3 Million Round

June 10, 2011 – Marlborough’s Spectra Analysis Instruments Inc. has raised $913,927 of a planned $3 million equity and options round, according to a filing with the U.S. Securities and Exchange Commission…read more